Table of Contents
Chapter 1. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Executive Summary
1.1. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Dynamics
3.1. Market Drivers
3.1.1. High research funding
3.1.2. Increasing aging population
3.1.3. Rising incidence of ALS
3.2. Market Challenges
3.2.1. High treatment costs
3.2.2. Stringent regulatory guidelines
3.3. Market Opportunities
3.3.1. Development of novel drugs
3.3.2. Increased awareness about ALS
Chapter 4. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Intravenous
5.2.2. Oral
Chapter 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size & Forecasts by Distribution Channel 2022-2032
6.1. Segment Dashboard
6.2. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
Chapter 7. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size & Forecasts by Region 2022-2032
7.1. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.1.1. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.1.1.1. Type breakdown size & forecasts, 2022-2032
7.1.1.2. Distribution Channel breakdown size & forecasts, 2022-2032
7.1.2. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.2. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.2.1. U.K. Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.2.2. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.2.3. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.2.4. Spain Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.2.5. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.2.6. Rest of Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.3. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.3.1. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.3.2. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.3.3. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.3.4. Australia Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.3.5. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.3.6. Rest of Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.4. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.4.1. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.4.2. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.4.3. Rest of Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.5. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.5.1. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.5.2. South Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market
7.5.3. Rest of Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Alkem Laboratories Ltd.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Apotex Inc.
8.3.3. Aquestive Therapeutics Inc.
8.3.4. Brainstorm Cell Therapeutics Inc.
8.3.5. CORESTEM Inc.
8.3.6. Dr Reddys Laboratories Ltd.
8.3.7. Eledon Pharmaceuticals Inc.
8.3.8. Ionis Pharmaceuticals Inc.
8.3.9. Italfarmaco Holding SPA
8.3.10. Medindia Health
8.3.11. Mitsubishi Chemical Group Corp.
8.3.12. Otsuka Holdings Co. Ltd.
8.3.13. AB Science SA
8.3.14. Biogen Inc.
8.3.15. Cytokinetics Inc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes